Cargando…
M2-TAMs promote immunoresistance in lung adenocarcinoma by enhancing METTL3-mediated m6A methylation
BACKGROUND: Immunotherapy has become the first-line treatment for advanced non-small-cell lung cancer (NSCLC), but most patients still fail to benefit or have disease progression following treatment. M2 phenotype tumor-associated macrophages (M2-TAMs) are important cellular components in the immunos...
Autores principales: | Wu, Lige, Cheng, Daoan, Yang, Xin, Zhao, Weiqing, Fang, Cheng, Chen, Rui, Ji, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843413/ https://www.ncbi.nlm.nih.gov/pubmed/36660648 http://dx.doi.org/10.21037/atm-22-6104 |
Ejemplares similares
-
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
por: Coelho, Matthew A., et al.
Publicado: (2017) -
Mettl3-mediated mRNA m(6)A methylation promotes dendritic cell activation
por: Wang, Huamin, et al.
Publicado: (2019) -
METTL3-mediated m(6)A RNA methylation promotes the anti-tumour immunity of natural killer cells
por: Song, Hao, et al.
Publicado: (2021) -
Highly Sensitive Immunoresistive Sensor for Point-Of-Care Screening for COVID-19
por: Li, Tianyi, et al.
Publicado: (2022) -
Roles of the m6A methyltransferases METTL3, METTL14, and WTAP in pulmonary tuberculosis
por: Zhang, Tian-Ping, et al.
Publicado: (2022)